A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

Clinical trial NCT02841540 · TERMINATED

Trial details

NCT number: NCT02841540
Sponsor: Hemavant Sciences GmbH
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Syndromes Leukemia, Myelomonocytic, Chronic

Start date: 2016-10-06
Primary completion: 2024-02-13
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.